{
	"symbol": "FRX",
	"name": "Fennec Pharmaceuticals Inc.",
	"price": 12.16,
	"priceChange": 0.27,
	"percentChange": 2.270816,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Biotechnology",
	"volume": 1210,
	"openPrice": 12.15,
	"dayHigh": 12.16,
	"dayLow": 12.14,
	"MarketCap": 335617350,
	"MarketCapAllClasses": 335543040,
	"peRatio": "",
	"prevClose": 11.89,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": 0.917961,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.",
	"fulldescription": "Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.",
	"website": "https://www.fennecpharma.com",
	"email": "info@fennecpharma.com",
	"phoneNumber": "+1 919 636-4530",
	"fullAddress": "68 TW Alexander Drive,PO Box 13628, Research Triangle Park, NC, US",
	"employees": "29",
	"shareOutStanding": 27600111,
	"totalDebtToEquity": "",
	"totalSharesOutStanding": 27594000,
	"sharesESCROW": null,
	"vwap": 12.1441666,
	"dividendPayDate": null,
	"weeks52high": 12.16,
	"weeks52low": 5.65,
	"alpha": 0.006788,
	"averageVolume10D": 953,
	"averageVolume20D": 809,
	"averageVolume30D": 627,
	"averageVolume50D": 573,
	"priceToBook": -41.75,
	"priceToCashFlow": -14.2,
	"returnOnEquity": "",
	"returnOnAssets": -21.55,
	"day21MovingAvg": 11.308095,
	"day50MovingAvg": 10.2386,
	"day200MovingAvg": 8.5809,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 12.16,
	"qmdescription": "Biotechnology",
	"__typename": "Company"
}